MktsMarkets

iRadimed Corporation
NASDAQ: IRMDKey statistics
IRMD News
Stories mentioning IRMD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 21,979 | 22,692 | 21,202 | 20,409 | 19,511 | 19,389 | 18,326 | 17,929 |
| Cost of Goods Sold | 5,165 | 5,660 | 4,708 | 4,454 | 4,668 | 4,629 | 4,134 | 3,919 |
| Gross Profit | 16,814 | 17,032 | 16,494 | 15,955 | 14,843 | 14,760 | 14,192 | 14,010 |
| Operating Expenses | ||||||||
| Research & Development | 956.00 | 800.00 | 674.00 | 877.00 | 624.00 | 571.00 | 639.00 | 801.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 9,577 | 9,938 | 9,661 | 9,167 | 9,411 | 8,960 | 8,403 | 8,383 |
| Operating Income (Loss) | 7,237 | 7,093 | 6,834 | 6,788 | 5,432 | 5,801 | 5,789 | 5,627 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 7,769 | 7,791 | 7,298 | 7,327 | 5,945 | 6,344 | 6,418 | 6,269 |
| Tax Provision | 1,951 | 1,349 | 1,721 | 1,553 | 1,258 | 1,197 | 1,369 | 1,368 |
| Net Income (Loss) | 5,818 | 6,442 | 5,577 | 5,774 | 4,687 | 5,147 | 5,049 | 4,901 |
| Earnings Per Share (Basic) | 0.46 | 0.51 | 0.44 | 0.45 | 0.37 | 0.41 | 0.40 | 0.39 |
| Earnings Per Share (Diluted) | 0.45 | 0.50 | 0.43 | 0.45 | 0.37 | 0.40 | 0.40 | 0.38 |
| Weighted Average Shares Outstanding (Basic) | 12,783 | 12,722 | 12,721 | 12,716 | 12,714 | 12,670 | 12,670 | 12,665 |
| Weighted Average Shares Outstanding (Diluted) | 12,870 | 12,854 | 12,860 | 12,835 | 12,826 | 12,784 | 12,778 | 12,758 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IRMD
iRadimed Corporation (NASDAQ: IRMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol IRMD. It last traded at $85.54 (Nov 5, 2026, 4:00 PM ET), down 3.4% on the day. That gives iRadimed a market capitalisation of $1.1B and a price-to-earnings ratio of 49.1.
Over the past 52 weeks IRMD has traded between $76.35 and $107.90.
Revenue for the quarter ended Mar 31, 2026 was $22.0M; net income $5.8M. Revenue was up 12.6% from $19.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $22.0M | $5.8M | 26.5% |
| Dec 31, 2025 | $22.7M | $6.4M | 28.4% |
| Sep 30, 2025 | $21.2M | $5.6M | 26.3% |
| Jun 30, 2025 | $20.4M | $5.8M | 28.3% |
From iRadimed’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…